PATENT CLAIM ANALYSIS

Application Number: 15775871
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "080000"]

Abstract:
The present invention relates to Spirocyclic Pyridotriazine Derivatives of Formula (I) and pharmaceutically acceptable salts thereof, wherein A, B, X, Y, R 1 , R 2  and R 16  are as defined herein. The present invention also relates to compositions comprising at least one Spirocyclic Pyridotriazine Derivative, and methods of using the Spirocyclic Pyridotriazine Derivatives for treating or preventing HIV infection in a subject.

Claim (Index 14):
A pharmaceutical composition comprising an effective amount of a compound according to  claim 1 , or a pharmaceutically acceptable salt or prodrug thereof, and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.42308
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15775966', '16061369', '15105376', '15560896', '15575433']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7895104755434847
- 35 USC 102 Novelty (BERT): 0.5963938973834753
- Combined Prediction Score: 0.7701988177274838
- Mean Citation Score: 452.614154
- Max Citation Score: 491.0582
- Similarity Product: 483.56536358618735

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test